Emerging precision therapeutics, pediatric screening programs, and expanded clinical pipelines are fueling growth in the primary hyperoxaluria treatment market, addressing unmet metabolic treatment needs. https://www.datamintelligence.com/research-report/primary-hyperoxaluria-treatment-market